Nebius Stock: $12 Billion in Signed Contracts, a $40–45 Billion 2027 Bill, and a Vineland Handover Pushed to Q2 2027
Published on 11/17/2026 at 11:10 | Editorial boerse-global.deNebius gave investors two very different things to chew on this week. On Thursday the company disclosed contract signings worth $12 billion, with management stating that customer prepayments cover the capital expenditure tied to those deals. The same day brought a less welcome admission: part of the planned capacity at its Vineland site in New Jersey has slipped into next year.
That split — demand locked in, delivery running late — is now the axis on which the Nebius story turns. The stock gained 2.1% today.
Where the money is going
The buildout is enormous by any measure. Nebius guided on Thursday to capital expenditure of $40 billion to $45 billion for 2027, against roughly $27 billion expected for the current year — an investment plan the company raised last week from earlier levels. Management framed the $12 billion in prepayments as covering the capex attached to those specific contracts, though the overall spending programme dwarfs that figure and must be justified by capacity that can actually be switched on and sold.
According to TechCrunch on Thursday, the handover of part of the Vineland capacity earmarked for Microsoft has been pushed to Q2 2027. The outlet also reported that temporary power generation at the site is being wound down sooner than expected.
Should investors sell immediately? Or is it worth buying Nebius?
A business that is already large
The delay debate lands against a base that has grown fast. Nebius reported third-quarter 2026 revenue of $980.8 million and adjusted EBITDA of $465.8 million. Year on year, sales rose 571%.
Those numbers do not prove the next expansion phase will go as smoothly. They do show that the growth case does not rest solely on future business — a later handover of additional capacity would attach to an already elevated revenue base.
For the full year, Nebius said last week that revenue will land at the low end of its prior range of $3.0 billion to $3.4 billion. For 2027, it has provisionally guided to revenue of $12 billion to $13 billion.
Citi trims, but stays on board
Citi analyst Tyler Radke cut his price target on Nebius yesterday to $215 from $265, keeping his buy recommendation. The reduction follows the delayed data-centre capacity and the trimmed near-term revenue outlook, according to media reports.
That combination is the instructive part: a constructive long-term view does not preclude a lower valuation, and an unchanged rating does not make the operational slippage disappear. Reuters reported last week that delays at third-party providers are pushing a portion of expected capacity into 2027.
Nebius at a turning point? This analysis reveals what investors need to know now.
What investors are actually grading
The distinction that matters is between a timing shift and a permanent loss. A deferral supports neither the conclusion that the later revenue is secured nor that it is gone. Progress on delivery is the test — and 2027 is the concrete reference point, since that is where a chunk of the expected capacity now sits.
The benign scenario has the deferred capacity come online and generate revenue, turning the issue into a matter of calendar rather than demand. The harsher one involves another slip, stretching the gap between the enlarged spending plan and capacity that actually produces sales. With $27 billion going out this year and as much as $45 billion slated for 2027, updates on when that capacity goes live may soon matter more to the share price than any further round of target changes.
Ad
Nebius Stock: New Analysis - 17 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
